3,449 Shares in Hamilton Lane Incorporated (NASDAQ:HLNE) Acquired by Bayesian Capital Management LP

Bayesian Capital Management LP acquired a new stake in Hamilton Lane Incorporated (NASDAQ:HLNE - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 3,449 shares of the company's stock, valued at approximately $511,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Price T Rowe Associates Inc. MD raised its stake in Hamilton Lane by 229.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 1,292,266 shares of the company's stock valued at $191,321,000 after buying an additional 900,283 shares in the last quarter. Vanguard Group Inc. lifted its stake in Hamilton Lane by 28.4% during the fourth quarter. Vanguard Group Inc. now owns 3,901,933 shares of the company's stock worth $577,681,000 after purchasing an additional 863,326 shares during the last quarter. Norges Bank acquired a new position in Hamilton Lane in the fourth quarter valued at approximately $68,909,000. Invesco Ltd. raised its holdings in Hamilton Lane by 25.3% during the fourth quarter. Invesco Ltd. now owns 1,923,253 shares of the company's stock worth $284,738,000 after purchasing an additional 388,019 shares in the last quarter. Finally, Artemis Investment Management LLP purchased a new stake in shares of Hamilton Lane during the 4th quarter worth approximately $30,350,000. 97.40% of the stock is currently owned by institutional investors and hedge funds.

Hamilton Lane Trading Down 1.7 %

Shares of HLNE stock opened at $157.71 on Wednesday. The company has a market capitalization of $8.74 billion, a P/E ratio of 29.10 and a beta of 1.31. The company has a current ratio of 4.19, a quick ratio of 4.19 and a debt-to-equity ratio of 0.34. The business's 50 day moving average is $145.87 and its two-hundred day moving average is $160.34. Hamilton Lane Incorporated has a twelve month low of $114.25 and a twelve month high of $203.72.

Hamilton Lane (NASDAQ:HLNE - Get Free Report) last posted its quarterly earnings data on Tuesday, February 4th. The company reported $1.25 earnings per share for the quarter, beating analysts' consensus estimates of $1.13 by $0.12. The firm had revenue of $168.26 million for the quarter, compared to analyst estimates of $158.86 million. Hamilton Lane had a net margin of 31.12% and a return on equity of 36.69%. Hamilton Lane's quarterly revenue was up 34.3% on a year-over-year basis. During the same period last year, the firm posted $0.71 EPS. Equities analysts forecast that Hamilton Lane Incorporated will post 4.97 EPS for the current year.

Hamilton Lane Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, April 4th. Stockholders of record on Friday, March 14th were paid a dividend of $0.49 per share. The ex-dividend date of this dividend was Friday, March 14th. This represents a $1.96 dividend on an annualized basis and a dividend yield of 1.24%. Hamilton Lane's dividend payout ratio (DPR) is 36.16%.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on HLNE shares. Morgan Stanley reduced their price target on shares of Hamilton Lane from $190.00 to $157.00 and set an "equal weight" rating for the company in a research report on Monday, April 14th. Oppenheimer raised Hamilton Lane from a "market perform" rating to an "outperform" rating and set a $186.00 target price for the company in a research report on Tuesday, January 21st. Keefe, Bruyette & Woods lifted their price target on Hamilton Lane from $158.00 to $168.00 and gave the stock a "market perform" rating in a research report on Wednesday, February 5th. JPMorgan Chase & Co. decreased their price objective on Hamilton Lane from $176.00 to $167.00 and set a "neutral" rating for the company in a report on Tuesday, April 29th. Finally, Wells Fargo & Company cut their target price on shares of Hamilton Lane from $152.00 to $147.00 and set an "equal weight" rating on the stock in a report on Tuesday, April 8th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the company. According to MarketBeat.com, Hamilton Lane presently has a consensus rating of "Hold" and a consensus target price of $164.14.

Hamilton Lane Profile

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.